Back
Akebia Therapeutics Vs. PTC Therapeutics Industry Stock Comparison
Buy
66
AKBA
Akebia Therapeutics
Last Price:
2.04
Seasonality Move:
28.83%
Sell
47
PTCT
PTC Therapeutics
Last Price:
49.82
Seasonality Move:
17.12%
Buy
66
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $2.04. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $2.04
The current trend is moderately bullish and AKBA is experiencing selling pressure, which indicates risk of future bearish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $50.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 64.07 | Buy |
Chaikin Money Flow: | -2084803 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.76 - 2.02) | Buy |
Bollinger Bands (100): | (1.26 - 1.76) | Buy |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.11 | Buy |
Relative Strength Index (14 RSI): | 66.75 | Buy |
Chaikin Money Flow: | -849912 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.04 - 46.16) | Buy |
Bollinger Bands (100): | (32.47 - 41.53) | Buy |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2 | Buy |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 1.63 | Buy |
200-day SMA: | 1.43 | Buy |
8-day EMA: | 2.01 | Buy |
20-day EMA: | 1.91 | Buy |
50-day EMA: | 1.72 | Buy |
200-day EMA: | 1.45 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.81 | Buy |
20-day SMA: | 43.67 | Buy |
50-day SMA: | 40.62 | Buy |
200-day SMA: | 34.19 | Buy |
8-day EMA: | 46.55 | Buy |
20-day EMA: | 44.07 | Buy |
50-day EMA: | 41.1 | Buy |
200-day EMA: | 35.83 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.
Akebia Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |